US 10913947
Antisense oligomers for treatment of conditions and diseases
granted A61KA61K9/0019A61K9/0085
Quick answer
US patent 10913947 (Antisense oligomers for treatment of conditions and diseases) held by STOKE THERAPEUTICS, INC. expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- STOKE THERAPEUTICS, INC.
- Grant date
- Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 79
- CPC classes
- A61K, A61K9/0019, A61K9/0085, A61P, A61P25/00